Heron Therapeutics
HRTX
HRTX
189 hedge funds and large institutions have $1.91B invested in Heron Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 64 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.63% less ownership
Funds ownership: 99.99% → 99.36% (-0.63%)
19% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 64
Holders
189
Holding in Top 10
4
Calls
$2.94M
Puts
$1.2M
Top Buyers
| 1 | +$70.3M | |
| 2 | +$22.4M | |
| 3 | +$18.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.58M |
Top Sellers
| 1 | -$42.9M | |
| 2 | -$29.7M | |
| 3 | -$9.07M | |
| 4 |
KCM
Kensico Capital Management
Greenwich,
Connecticut
|
-$8.03M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$7.13M |